Cargando…
Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD(4)-selective WNT surrogate in mice
Derangements of the blood-brain barrier (BBB) or blood-retinal barrier (BRB) occur in disorders ranging from stroke, cancer, diabetic retinopathy, and Alzheimer’s disease. The Norrin/FZD(4)/TSPAN12 pathway activates WNT/β-catenin signaling, which is essential for BBB and BRB function. However, syste...
Autores principales: | Ding, Jie, Lee, Sung-Jin, Vlahos, Lukas, Yuki, Kanako, Rada, Cara C., van Unen, Vincent, Vuppalapaty, Meghah, Chen, Hui, Sura, Asmiti, McCormick, Aaron K., Tomaske, Madeline, Alwahabi, Samira, Nguyen, Huy, Nowatzke, William, Kim, Lily, Kelly, Lisa, Vollrath, Douglas, Califano, Andrea, Yeh, Wen-Chen, Li, Yang, Kuo, Calvin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238527/ https://www.ncbi.nlm.nih.gov/pubmed/37268690 http://dx.doi.org/10.1038/s41467-023-37689-1 |
Ejemplares similares
-
SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy
por: Nguyen, Huy, et al.
Publicado: (2022) -
Robust Colonic Epithelial Regeneration and Amelioration of Colitis via FZD-Specific Activation of Wnt Signaling
por: Xie, Liqin, et al.
Publicado: (2022) -
Bioengineering of bacteria for cancer immunotherapy
por: Nguyen, Dinh-Huy, et al.
Publicado: (2023) -
Decrease of FZD4 exon 1 methylation in probands from FZD4-associated FEVR family of phenotypic heterogeneity
por: Liu, Miaomiao, et al.
Publicado: (2022) -
FZD7: A potential biomarker for endometriosis
por: Lan, Suwei, et al.
Publicado: (2023)